Abstract. Bone marrow-derived mesenchymal stem cells (BM-MSCs) have been shown to attenuate ischemia reperfusion (IR) injury in the heart, brain and kidney. However, their exact roles in the liver remain to be defined. Our objective was to investigate the potential effects of BM-MSCs on a hepatic IR rat model during the first 24 h after reperfusion, a crucial period for hepatic IR damage formation. A rat model of normothermic partial hepatic ischemia was obtained by vascular clamping for 60 min. BM-MSCs were transplanted via portal vein injection. Injury severity, oxidative stress response and apoptosis of liver cells were assessed at 2, 6, 12 and 24 h after reperfusion and cell transplantation was evaluated. At 12 and 24 h after reperfusion, rats transplanted with BM-MSCs had significantly lower serum levels of alanine aminotransferase (ALT) and serum aspartate aminotransferase (AST), fewer damaged liver tissues, higher superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities and lower malondialdehyde (MDA) levels compared to rats in the sham transplantation group. At 24 h after reperfusion, IR rats transplanted with BM-MSCs had significantly fewer apoptotic hepatocytes, higher levels of B-cell lymphoma 2 (Bcl-2) protein, and lower levels of Bcl-2-associated X (Bax) and caspase-3 (Casp3) proteins compared to sham transplantation rats. In conclusion, BM-MSCs transplanted via the portal vein partially prevent hepatic IR injury by suppressing oxidative stress and inhibiting apoptosis during the first 24 h after reperfusion.
Introduction
Due to the necessary clamping of the hepatic pedicle during resection of liver tumor or liver transplantation, hepatic ischemia/reperfusion (IR) injury occurs with the resumption of oxygen delivery to the liver, aggravating ischemia injury, and is considered the major cause for surgical failure (1) . Reactive oxygen species (ROS) production is increased in response to IR. Ischemia is characterized by ATP depletion and oxygen free radical production (2, 3) . Also, dysregulated electron transport chain in mitochondria may contribute to increased oxidative stress (4). However, the major source of ROS following reperfusion has been shown to be the resident macrophages in the liver, or Kupffer cells (5, 6) . In an early phase (up to 6 h after reperfusion), Kupffer cells are activated, leading to increased ROS production and secretion of proinflammatory cytokines (7) . In the late phase (6-24 h after reperfusion), recruitment of neutrophils and T-lymphocytes further increases the synthesis of ROS, signaling molecules and complement factors (8) . Apoptosis is also increased in response to oxidative stress and inflammation (9) . Therefore, ROS play a crucial role in the pathology of hepatic IR injury.
Mesenchymal stem cells (MSCs) are adult stem cells. Similar to other stem cells, they can renew themselves and are capable of multipotent differentiation. MSCs are considered suitable for repairing damaged organs as they are non-immunogenic and immunosuppressive cells able to differentiate into different lineages, and as they secrete a number of cytokines (10) . Preventing IR damage using MSCs has been shown in the brain (11) , heart (12) , and kidney (13) . Previous studies showed that both MSCs and MSC-conditioned medium have the potential to improve the hepatic condition in rat models of liver fibrosis or acute hepatic failure (14) . These studies indicate that the hepatoprotective effects of MSCs are mainly due to their paracrine function (15, 16) .
However, it remains unclear whether bone marrow-derived mesenchymal stem cells (BM-MSCs) could also ameliorate hepatic damage induced by IR injury. Therefore, in the present study, we generated a rat model of hepatic IR injury that closely mimics clinical conditions. Using this model, we investigated the protective role of BM-MSCs and the underlying molecular mechanisms during the first 24 h after reperfusion.
Materials and methods
Animals and experimental design. Seventy-two male Wistar rats (weighing 230-250 g and aged 8-10 weeks) were used for this study. Prior to the experiments, the rats were housed under standard conditions at the Animal Center of the Second Affiliated Hospital, Harbin Medical University. Experimental procedures used in this study were approved by the Administrative Panel on Laboratory Animal Care of Harbin Medical University.
Rats were randomly divided into three groups of 24 rats in each group. Rats in the sham-operated group were treated by laparotomy only; rats in the other two groups were subjected to IR. Upon reperfusion, the IR-transplanted group was immediately injected with BM-MSCs via the hepatic portal vein, while the IR-control group was injected with phosphatebuffered saline (PBS) in the same manner. At 2, 6, 12 or 24 h after IR, 2 ml of blood was collected from the inferior vena cava of 6 rats from each group before the animals were euthanized to harvest their livers.
Isolation of BM-MSCs. BM-MSCs were isolated using the density centrifugation method as previously described (17) . Briefly, whole BM cells were flushed from the femurs and tibias of male 4-week old Wistar rats, and then fractionated in Lymphoprep™ density solution (density 1.077; Nycomed Pharma, Oslo, Norway). Following centrifugation at 800 x g for 20 min, the cells at the interface were collected and suspended in Dulbecco's modified Eagle's medium and Ham's F-12 nutrient mixture (DMEM/F12; Gibco-Invitrogen Inc., Carlsbad, CA, USA) containing 10% fetal bovine serum (HyClone-Thermo Fisher Scientific, Waltham, MA, USA) and 1% penicillin/streptomycin. Cells were incubated at 37˚C with 95% humidity and 5% CO 2 . Forty-eight hours later, the culture medium was changed to remove non-adherent cells.
Labeling of BM-MSCs.
To trace BM-MSCs following transplantation, we labeled them with the fluorescent dye PKH26 (Sigma, St. Louis, MO, USA), according to the manufacturer's instructions. Labeled cells were then cultured in growth medium for at least 24 h before transplantation.
Induction of hepatic IR injury and cell transplantation.
Rats were anesthetized with pentobarbital sodium (60 mg/kg). A midline laparotomy was performed under aseptic conditions, the portal circulation to the left lateral and median lobes of the liver was carefully dissected, and a microaneurysm clamp was placed on the hepatic artery and portal vein to block the blood supply to these lobes. This treatment caused ischemia of 70% of the segmental liver and prevented mesenteric venous (18) . The clamp was removed after 60 min and, immediately, 1x10 6 PKH26-labeled MSCs resuspended in 200 µl PBS or PBS alone were injected into the portal vein with a 30-gauge needle. Sham-operated rats received only the laparotomy. Surgery was closed with 4/0 silk suture. When fully awake, rats had free access to food and water. During the entire procedure, the core body temperature of each rat was continuously monitored with a rectal probe and maintained at 37.0±0.4˚C with a heating lamp.
Measurement of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
To estimate the degree of hepatic IR injury, we measured the levels of serum AST and ALT. Rats were anesthetized as described above, and 2 ml of blood was collected from the inferior vena cava with a 20-gauge needle, placed in a microtainer tube with serum separator (Eppendorf, Hamburg, Germany), and centrifuged at 4,000 x g for 12 min. AST and ALT levels in the serum were measured using an automatic analyzer (Hitachi, Tokyo, Japan) and expressed as U/L.
Histological analysis. Livers were fixed in 10% buffered formalin, embedded in paraffin, and cut into 5 µm sections. Sections were stained in hematoxylin and eosin (H&E) and observed with a Nikon Eclipse 80i microscope (Nikon, Tokyo, Japan) connected to a DXM1200F digital camera. The severity of the liver injury was assessed in accordance with the modified Suzuki classification (19) , modified, by a pathologist who was blinded to the experimental design. Scores for severity were: none, 0; minimal, 1; moderate, 2; and severe, 3. For each rat, three liver sections were examined and three randomly selected high-power fields (x100) were analyzed in each section. The mean score for each animal was then determined by summation of all scores, divided by 9.
Assays for superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) in livers.
A portion of the injured rat liver was harvested and homogenized in ice-cold 0.9% saline. Following centrifugation at 1,500 x g for 15 min, the supernatant was collected and used to measure the activity of SOD, GSH-Px and MDA using SOD, GSH-Px, or MDA detection kits (Nanjing Jiancheng Biotech, Nanjing, China), respectively, in accordance with the manufacturer's instructions (20) .
Detection of apoptotic cells in liver tissues.
We used a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) kit (Roche Applied Science, Penzberg, Germany) to detect the apoptotic hepatocytes (21) . Liver sections (5 µm) were stained and six sections were analyzed for each rat. Numbers of apoptotic cells and total hepatic cells in each section were counted in three randomly selected fields (x400). An apoptosis index (AI) was expressed as the mean percentage of apoptotic cells within the total number of hepatic cells for each animal.
Western blot analysis. Whole protein extracts were prepared from liver tissues. Freshly harvested liver tissues were homogenized in a radioimmunoprecipitation assay (RIPA) lysis buffer (Solarbio Shanghai, China) and centrifuged at 12,000 x g for 15 min. The protein concentration in the supernatant of each sample was measured with a DCTM Protein Assay Kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. Proteins were separated using a 12% polyacrylamide gel, and then transferred to immunoblot polyvinylidene difluoride (PVDF) membranes. After blocking in 5% milk in Tris-buffered saline containing 0.05% Tween-20 at room temperature, membranes were serially incubated with the following primary antibodies: mouse anti-Actb, rabbit anti-B cell lymphoma 2 (Bcl-2), rabbit anti-Bcl-2-associated X protein (Bax), and rabbit anti-caspase-3 (Casp3) (1:200 dilution; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at 4˚C overnight. Membranes were then washed and incubated with fluorescence-conjugated anti-mouse or anti-rabbit IgG (1:2,000 dilution; Invitrogen). The bound secondary antibodies were analyzed with an Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA), normalized to β-actin.
Statistical analysis. SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. For multiple comparisons, data were analyzed using analysis of variance (ANOVA). Analysis between two groups was performed using the unpaired Student's t-test (two-tailed) where ANOVA indicated significance for the multiple comparisons. Data are reported as mean ± standard deviation. A P-value <0.05 was considered to indicate a statistically significant difference.
Results

Effect of transplanted BM-MSCs on ALT and AST serum levels.
To determine the degree of IR-induced hepatic injury in the rat livers receiving BM-MSCs or PBS, we measured ALT and AST levels in sera collected at 2, 6, 12 and 24 h after IR induction and cell transplantation. Compared to the sham-operated rats, ALT and AST levels in IR model rats were higher at every time-point, with the greatest difference 6 h after induction (Fig. 1 ). This suggests that IR injury was successfully induced in the IR model rats. At 12 and 24 h after reperfusion, ALT and AST levels in the IR-transplanted group significantly decreased compared to the IR-control group. This suggests that the transplantation of BM-MSCs had a protective effect against hepatic injury induced by the IR injury. (Fig. 2) .
Dynamic distribution of transplanted BM-MSCs in IR-induced livers.
We therefore investigated the distribution pattern of BM-MSCs transplanted via the portal vein as a function of time. BM-MSCs were stained by PKH26 fluorescent dye in vitro. We observed that at 2 h, transplanted PKH26-labeled cells were clustered around the main branches of the portal triad; at 6 h, these cells had moved to the periportal area, and at 12 and 24 h they were scattered within the portal tract areas (Fig. 3) .
Transplanted BM-MSCs attenuate the oxidative stress response in IR-induced livers. Previous studies have shown that the oxidative stress response is involved in IR-induced liver injury. We therefore assessed if transplanted BM-MSCs would attenuate the oxidative stress response in liver IR injury, by comparing SOD and GSH-Px activity levels, and MDA levels. We observed that SOD and GSH-Px levels were markedly decreased and that MDA levels markedly increased at 2, 6, 12 and 24 h in IR model rats compared with the shamoperated rats. This suggests that oxidative stress was indeed involved in IR-induced liver injury. Furthermore, we observed that transplantation of BM-MSCs significantly increased SOD and GSH-Px levels and significantly decreased MDA levels at 12 and 24 h, compared to rats in the IR-control group (Fig. 4) . These results indicate that transplanted BM-MSCs attenuated the oxidative stress response in IR-induced liver injury.
Transplanted BM-MSCs inhibit apoptosis in IR-induced livers.
Increased oxidative stress in a tissue often results in apoptosis. We therefore examined apoptotic activity in the IR-model rat livers and if the transplantation of BM-MSCs protected cells from apoptosis. We first assessed apoptotic cells in the livers using TUNEL staining, and then analyzed the expression levels of the anti-apoptotic protein, Bcl-2, and the pro-apoptotic proteins, Bax and Casp3. Twenty-four hours after reperfusion and cell transplantation, the livers from the IR-model rats had a markedly higher apoptotic index than those from the sham-operated rats, suggesting that IR induction caused hepatic apoptosis (Fig. 5) . This was further confirmed by a significant decrease in Bcl-2 levels, and by significant increases in Bax and Casp3 levels in IR-injured livers (Fig. 6) . The apoptotic index was lower in livers from the IR-transplanted rats (Fig. 5) , Bax and Casp3 levels were lower, and Bcl-2 levels were higher. Collectively, these results indicate that the transplanted BM-MSCs had a protective effect against apoptosis in the IR-induced livers.
Discussion
In the present study, we investigated the damage and molecular mechanisms of liver IR injury in a rat model as well as the protective role of BM-MSCs during the crucial first 24-h period. We found evidence of IR injury during the first 24 h after reperfusion. From 2 h after reperfusion, AST and ALT serum levels were higher than in the sham-operated rats and severe damage was observed in the histopathology. In addition, evidence of increased oxidative response was observed from 2 h after reperfusion, while apparent apoptosis was observed at 24 h. We also observed that BM-MSCs transplanted via the portal vein exerted a protective effect against hepatic IR damage during the late phase following reperfusion. This observation was further supported by the dynamic distribution of BM-MSCs; 24 h after reperfusion, the majority of the cells were scattered in the portal tract area of the livers.
For a therapeutic use of stem cells to be efficient, cells must be easy to isolate, available in large amounts, able to expand in vitro, and able to survive in vivo in sometimes harsh conditions. Based on these criteria, BM-MSCs are suitable candidates (22) . Once injected, they are recruited at the site of injury via homing mechanisms involving the CXCR4 receptor and the stromal derived factor-1 (SDF-1) (23). Once implanted, stem cells improve the injured tissue by secreting growth factors [including vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and insulin-like growth factor 1 (IGF-1)] (24,25) , by differentiating into organ cells, by transdifferentiating the organ cells and by inducing neovascularization (11) (12) (13) . Results from the present study are in agreement with results obtained from studies of other organs, such as the heart (12), brain (11) and kidney (13) .
Our results show that BM-MSCs homed to IR-injured liver tissue and improved liver conditions, as assessed by apoptosis measurement. Also, the protective role of BM-MSCs was observed during the late phase of the crucial period (from 12 to 24 h after reperfusion) of IR damage induction, indicating that BM-MSCs were viable and able to function in a short time after transplantation. Differentiating into hepatocytes or hepatocyte-like cells requires time; therefore, it is more likely that the short-term effects of transplanted BM-MSCs on IR injury were achieved via a paracrine mechanism, rather than via repopulation. The oxidative stress response has long been recognized as central to the pathogenesis of hepatic IR injury (26) . In the present study, we observed that at 2, 6, 12 and 24 h after reperfusion, the levels of the antioxidative enzymes SOD and GSH-Px were significantly decreased, while MDA levels, a marker for oxidative activity, was significantly increased, compared with the sham-operated control rats. Therefore, our observations are consistent with other studies showing that the oxidative stress response is involved in the formation of hepatic IR injury in the first 24 h.
We demonstrated in the present study that BM-MSCs transplanted via the portal vein attenuated the oxidative stress response in IR-injured livers. The suppressive role of BM-MSCs in the oxidative stress response was also observed in other studies of drug-induced animal models of liver disease. In a mouse model of liver cirrhosis induced by carbon tetrachloride (CCl 4 ), transplantation of human BM-MSCs suppressed the oxidative stress response and improved liver conditions (27) . In a rat model of hepatic injury induced by CCl 4 , administration of BM-MSCs induced a cytoprotective response by an antioxidative process (28) . MSC suppression of the oxidative stress response was also shown in rats with IR-induced lung and kidney injury (29) . Our study showed that at 12 and 24 h after reperfusion, the BM-MSC transplants attenuated the decrease in SOD and GSH-Px, and the increase in MDA, that otherwise occurred in the IR-control rats that received PBS only. These results indicate that BM-MSCs are capable of reducing the oxidative stress response in livers subjected to IR injury.
Apoptosis plays an important role in IR-injured liver and is triggered either by the mitochondria or by tumor necrosis factor (TNF) signaling. Indeed, hypoxia leads to reduced ATP production and ATP-dependent cellular events are stopped (30) . Mitochondria also regulate apoptosis by caspase activation (31) . Hypoxia-induced injury also induces an immune response resulting in the secretion of cytokines (including TNF, SDF-1 and interleukins) and the attraction of a number of cells, including MSCs. TNF signaling activates caspases, resulting in apoptosis (32) . During reperfusion, immune and endothelial cells are activated and produce ROS, which directly damage nearby cells and activate Ras, increasing apoptosis (33) . In a mouse model of IR-induced hepatic injury, administrating the antioxidant mangafodipir reestablished oxidative balance and suppressed apoptosis (34) . Using the same mouse model, Yu et al (35) demonstrated that the Notch-Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway protected hepatocytes from IR injury by attenuating oxidative stress and inhibiting apoptosis in vitro and in vivo. In the present study, we observed apoptosis in liver tissues subjected to IR 24 h after reperfusion, as shown by an increased apoptotic index, decreased expression of Bcl-2, and increased expression of Bax and Casp3. Furthermore, we showed that transplantation of BM-MSCs via the portal vein decreased apoptosis. Therefore, our results are consistent with previous studies suggesting that apoptosis is involved in IR-induced hepatic injury and that BM-MSCs inhibit apoptosis.
BM-MSCs inhibit hepatocyte apoptosis by secreting cytokines, thus regulating cellular signal transduction pathways. In rats, BM-MSCs secrete VEGF, which attenuates myocardial IR injury by activating the PI3K signaling pathway (36) , and the PI3K pathway can regulate the expression of Bcl-2, an antiapoptotic protein (37) . In rat neurons, MSCs secrete cytokines that reduce chronic ethanol-induced injury by modulating the extracellular-signal-regulated kinase (ERK)1/2 pathway (38). The ERK1/2 pathway regulates apoptosis by increasing the Bax/Bcl-2 ratio, Casp3 levels and TNF levels (39) . In the present study, we observed, at 24 h after reperfusion and BM-MSC transplantation, that Bcl-2 levels, an anti-apoptotic protein, was increased, and that the expression levels of pro-apoptotic proteins, Bax and Casp3, were decreased. We thus inferred that BM-MSCs inhibit apoptosis in IR-induced hepatic injury via their paracrine activity.
In conclusion, we demonstrated that in a rat model of IR injury, hepatic injury occurred within 24 h of reperfusion and that the oxidative stress response and subsequent apoptosis were involved in the process of hepatic IR damage. We also observed that BM-MSCs transplanted via the portal vein could attenuate IR injury by, at least in part, suppressing the oxidative stress response and inhibiting apoptosis.
